STING1 and neoplasm: This self‐propelled, in situ polymerized nanodrug instillation system enhances therapeutic outcomes by activating the STING pathway and promoting DCs maturation, which subsequently activates T cells, induces tumor cytotoxicity, and enhances the immunogenicity of the TME (Figure 1).